Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

LAVA Medtech Acquisition Corp. LVAC NASDAQ

NASDAQ Global Market • Financial Services • Shell Companies • US • USD

SharesGrow Score
47/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

LAVA Medtech Acquisition Corp. (LVAC) is a Shell Companies company in the Financial Services sector, currently trading at $10.43. It has a SharesGrow Score of 44/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Net income is $5M, growing at -74.9%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $0 against $116M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 0.29 (tight liquidity). Debt-to-assets is 0%. Total assets: $121M.

SharesGrow 7-Criteria breakdown: Value 40/100 (Partial), Growth 15/100 (Fail), Past 100/100 (Pass), Health 50/100 (Partial), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

LVAC SharesGrow Score Overview

47/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 40/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — LVAC

~
VALUE Partial
40/100
LVAC trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✗
GROWTH Fail
15/100
LVAC: +0%/yr revenue is, -74.9%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
PAST Pass
100/100
LVAC: 2 / 2 years profitable. strong — 100%. Score = 2 / 2 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
50/100
Balance sheet LVAC: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 0.29 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
LVAC: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range9.94-10.85
Avg Volume (30D)44.33K
Market Cap$149.93M
Beta (1Y)0.00
Share Statistics
EPS (TTM)0.31
Shares Outstanding$14.38M
IPO Date2021-12-17
CEOAnthony Natale
Financial Highlights & Ratios
EBITDA$-6.22M
Net Income$4.51M
Operating Income$-1.56M
Total Cash$1.16M
Net Debt$-1.16M
Total Assets$120.67M
Price / Earnings (P/E)33.6
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD

Price Chart

Track all markets on TradingView
LVAC
LAVA Medtech Acquisition Corp.  ·  NASDAQ Global Market
Financial Services • Shell Companies
9.94 52WK RANGE 10.85

People Also View

CFFS
CFFS
CF Acquisition Corp. VII
$11.28
-0.09%
 IVCPU
IVCPU
Swiftmerge Acquisition Corp.
$9.20
-1.29%
 NUBI
NUBI
Nubia Brand International Corp.
$4.53
-21.35%
 CLAYU
CLAYU
Chavant Capital Acquisition Corp.
$10.97
+18.34%
 VBOCU
VBOCU
Viscogliosi Brothers Acquisition Corp.
$10.47
-0.10%
 VTSAX
VTSAX
Vanguard Total Stock Market Index Fund Admiral Shares
$164.90
+1.12%
 VSMPX
VSMPX
Vanguard Total Stock Market Index Fund Institutional Plus Shares
$309.37
+1.11%
 VITSX
VITSX
Vanguard Total Stock Market Index Fund Institutional Shares
$164.92
+1.12%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message